HIV-Infected Patients Frequently Have Chronic Pain

This article originally appeared here.
Share this content:
HIV-Infected Patients Frequently Have Chronic Pain
HIV-Infected Patients Frequently Have Chronic Pain

TUESDAY, July 7, 2015 (HealthDay News) -- Many HIV-infected patients have chronic pain, which frequently co-occurs with high levels of depression symptoms, according to a study published online June 27 in Pain Medicine.

Lisa A. Uebelacker, Ph.D., from the Butler Hospital in Providence, R.I., and colleagues conducted a cross-sectional study involving 238 HIV-infected primary care patients at three primary care sites. Self-report and chart-review information were collected on demographics, HIV clinical status, chronic pain, depression, substance use, and mental health and pain treatment.

The researchers found that 107 participants reported no chronic pain, 24 reported mild chronic pain, and 107 reported moderate-severe chronic pain. Participants were more likely to have high levels of depressive symptoms in the moderate-severe pain group versus the no chronic pain group. A significant correlation was seen between chronic pain status and interference with life activities due to pain. The likelihood of taking an antidepressant medication was increased for participants with moderate-severe chronic pain versus those with mild chronic pain; prescription opioid use was more likely for those with moderate-severe chronic pain versus those with mild or no chronic pain. There was no correlation between problematic substance use and chronic pain status.

"Despite pharmacologic treatment, moderate-severe chronic pain and elevated depression symptoms are common among HIV-infected patients and frequently co-occur," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »